FEB 08, 2017 01:30 PM PST

Managing genetically modified rodent strains: focus on the genotype and genetic background

Speakers
  • Professor of Microbiology and Immunology, and Genetics, Geisel School of Medicine at Dartmouth
    Biography
      Dr. Fiering received his Bachelor of Science from the University of Michigan in 1975, and his Doctorate from Stanford in 1990. After postdoctoral work as an NIH research fellow and research associate at the Fred Hutchinson Cancer Research Center, Dr. Fiering joined the faculty of the Department of Microbiology at Dartmouth Medical School in 1997. At that time he established a transgenic animal production facility at Dartmouth and this has become the current Mouse Modeling Shared Resource which provides an extensive line of services around generation, analysis and utilization of genetically modified mice.

    Abstract:

    DATE: February 8, 2017
    TIME: 1:30pm PT, 4:30pm ET

    The powerful and expanding use of genetically modified mice introduces important aspects of genetics in managing these strains for breeding and experimental usage. This management takes on increasing importance within the current backdrop of focus by NIH on “rigor and reproducibility”, which means that increasingly grant and paper reviewers will expect specific data to support the stated genotype of an experimental mouse strain. We should recognize that this genotype includes both the specific genetic modification in the mice as well as the overall genetic background of these mice. The first issue is the need to genotype many of these strains for the desired genetic modification and the challenges that involves.  While genotyping of some genetically modified mouse strains is not particularly difficult, some strains can be quite challenging, and any genotyping is exacerbated when a lab is not accustomed to basic molecular biology studies.  

    Specific challenges of genotyping each strain is unique to that strain but fundamentally it involves developing and utilizing a genotyping strategy that is most often dependent on polymerase chain reaction (PCR) for the assay.  Those who have worked with PCR know that each reaction has its own unique challenges of dependability that are impacted by many variables such as DNA prep, buffer, PCR machine parameters (temperature time and number of cycles), appropriate gel system to visualize the data if the assay is scored visually as opposed to a quantitative PCR.  Against the basic challenge of genotyping are unique aspects of each strain such as whether it is homozygous, hemizygous or heterozygous, and whether the modification is on a sex chromosome and whether more than one modification is involved and whether they are genetically linked in close physical proximity or unlinked on different chromosomes. A recent complexity in genotyping is the development of CRISPR knockout strains in which the mutation is different in each founder and each founder’s offspring have different challenges in genotyping.  Every strain of genetically modified mouse is unique and must be specifically genotyped appropriately every time or the genetics of the colony are disrupted and experiments fail after significant investment.  Another important issue in rigor and reproducibility is genetic background.  Genetically modified mice are made in a mixed or inbred background but for experimental reasons they are often backcrossed into other inbred backgrounds.  The genetic background has a major impact on results of many experiments.  However, genetic background is rarely directly assessed because historically it has been very difficult.  There now exists a shared resource at Dartmouth known as “DartMouse” that is under my direction, which is able to efficiently validate the genetic background of individual mice.  
     


    Show Resources
    You May Also Like
    SEP 05, 2019 04:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 04:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JUN 05, 2019 05:00 PM CEST
    C.E. CREDITS
    JUN 05, 2019 05:00 PM CEST
    DATE: June 5, 2019TIME: 8:00am PDT, 11:00am EDT, 5:00pm CEST Eukaryotic cell cultures respond to the most subtle influence. Apart from the risk of contamination, minimal chan...
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    OCT 02, 2019 11:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: October 2, 2019TIME: 11:00am PDT, 2:00pm EDT Ditch the Excel spreadsheets and manage your molecular workflows entirely in your LIMS Achieve configuration of molecular workf...
    AUG 27, 2019 09:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 09:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    MAY 16, 2019 04:00 PM CEST
    C.E. CREDITS
    MAY 16, 2019 04:00 PM CEST
    DATE: May 16, 2019TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST The emergence of NGS is revolutionizing the microbiological sciences and transforming medicine. Deep sequencing has...
    JUL 30, 2019 10:00 AM PDT
    C.E. CREDITS
    JUL 30, 2019 10:00 AM PDT
    DATE: July 30, 2019TIME: 10:00am PT/ 1:00pm ET The importance of building a validation structure within your lab cannot be overstated. Once in place, the ability to identify high...
    Loading Comments...
    Show Resources
    Attendees